ArticleHealth science reports2026
Impact of the COVID-19 Pandemic on Cancer Management in Iran: A Review.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Globally, the emergence of the COVID-19 pandemic profoundly impacted cancer management. This review discusses the different perspectives on the effect of the pandemic on cancer care in Iran. Methods: The literature search yielded 38 articles on cancer management in Iran during the COVID-19 pandemic. This study evaluated multiple aspects of cancer management, including screening, diagnosis, surgical and pharmacological management, palliative care, psychological aspects, telemedicine, cancer research, and guidelines and recommendations during the pandemic. Results: Studies indicate that cancer patients are at a heightened risk of severe COVID-19 infections, with a high risk of requiring invasive ventilation, hospitalization in the ICU, and subsequent death. The pandemic significantly affected cancer screenings, in turn leading to a greater number of advanced disease presentations. Furthermore, some surgical and pharmacological treatments were deferred, complicating risk-benefit assessments resulted in complex and challenging decisions regarding patient care. Cancer patients experienced substantial psychological distress, which was exacerbated by delays in treatment and anxiety about contracting COVID-19. The commentary highlights the critical importance of adaptive measures, such as telemedicine and home-based palliative care, to minimize the effects of future health crises on cancer care. Conclusion: The significant impact of the pandemic on cancer care highlights the critical nature of ensuring that cancer care is a top priority during public health emergencies to achieve equitable access and quality patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.